Рубрика
Blog
-
2023
-
FDA Pauses IND Submission for Duchenne Therapy ENTR-601-44
-
FDA Expands Approval for Cytalux Imaging for Lung Cancer Detection
-
AbbVie’s Vraylar Gets Expanded Approval for Major Depressive Disorder
-
FDA Approves First Gene Therapy for Specific Form of Bladder Cancer
-
Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON
-
Kintara’s VAL-083 Gets Orphan Drug Status for Rare Childhood Cancer
-
Centrient API Plant Receives Warning Letter
-
Prime to Cover Biosimilars Alongside Humira
-
Intranasal Therapy for Major Depressive Disorder Gets Fast Track Status
-
USP and Phlow Partner to Validate Continuous Manufacturing Processes